The objectives of this platform are to create partnerships and to provide specialised services to researchers and industry partners through three principle streams of activity:

• Comprehensive phenotypic assessments (behaviour, morphology, physiology and pharmacology) of animal models affected by genetic, mechanical or pharmacological manipulation
  
  
• In Vivo preclinical testing for the pharmaceutical and biotechnology industries, including the testing of receptors and molecules in brain activity
  
  
• Intramural neurobiological research to develop new knowledge, Intellectual Property and commercially viable therapeutics for the major neurological and psychiatric disorders